Kuroha Takashi, Furukawa Tatsuo, Yoshikawa Seiichi, Kaihatsu Akane, Nemoto Hiroki, Usuda Hiroyuki, Yano Toshio
Department of Hematology, Nagaoka Red Cross Hospital, 2-297-1, Senshu, Nagaoka, 940-2085, Japan.
Department of Gastroenterology, Nagaoka Red Cross Hospital, 2-297-1, Senshu, Nagaoka, 940-2085, Japan.
Int J Hematol. 2025 Mar;121(3):421-426. doi: 10.1007/s12185-024-03909-7. Epub 2025 Jan 5.
Sinusoidal obstruction syndrome (SOS), also known as hepatic veno-occlusive disease (VOD), is a life-threatening complication of hematopoietic stem cell transplantation. In severe cases, SOS/VOD progresses to multiple organ failure with a mortality rate higher than 80%. Early diagnosis and treatment based on severity assessment improve the prognosis of severe SOS/VOD, but conventional diagnostic criteria may be insufficient for an early diagnosis. We herein report a case of severe late-onset SOS/VOD that was histologically proven before clinical findings become evident. Although defibrotide therapy was started before the clinical diagnostic criteria were met, the disease progressed to multiple organ failure. This case suggests that some patients require earlier treatment before the appearance of clinical findings such as ascites and weight gain or hyperbilirubinemia, and supports the need to establish methods for predicting the onset and severity of SOS/VOD.
窦性阻塞综合征(SOS),也称为肝静脉闭塞病(VOD),是造血干细胞移植的一种危及生命的并发症。在严重情况下,SOS/VOD会进展为多器官功能衰竭,死亡率高于80%。基于严重程度评估的早期诊断和治疗可改善严重SOS/VOD的预后,但传统诊断标准可能不足以进行早期诊断。我们在此报告一例严重迟发性SOS/VOD病例,在临床症状明显之前经组织学证实。尽管在符合临床诊断标准之前就开始了去纤苷治疗,但疾病仍进展为多器官功能衰竭。该病例表明,一些患者在出现腹水、体重增加或高胆红素血症等临床症状之前需要更早的治疗,并支持建立预测SOS/VOD发病和严重程度方法的必要性。
Biol Blood Marrow Transplant. 2017-6
Blood Adv. 2018-6-26
Expert Rev Gastroenterol Hepatol. 2017-9-4
Biol Blood Marrow Transplant. 2018-3-1
Int J Hematol. 2019-5-18